-+ 0.00%
-+ 0.00%
-+ 0.00%

Sol-Gel Technologies to host KOL investor event on SGT-610 for Gorlin syndrome

PUBT·09/30/2026 13:03:30
Sol-Gel Technologies to host KOL investor event on SGT-610 for Gorlin syndrome
  • Sol-Gel Technologies will host a KOL investor event on SGT-610 (patidegib gel, 2%) on Oct. 14, 2026 in New York.
  • Discussion will focus on Gorlin syndrome disease burden, highlighting the lack of effective therapies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004668), on September 30, 2026, and is solely responsible for the information contained therein.